Description:Maximize Market Research’s latest report, ” Global Immunoassay Market Global Demand Analysis and Opportunity Outlook 2027″, offers a comprehensive analysis of the market. It provides market segments by type and shape, as well as end-user industries and regions.
Global Immunoassay... moreMaximize Market Research’s latest report, ” Global Immunoassay Market Global Demand Analysis and Opportunity Outlook 2027″, offers a comprehensive analysis of the market. It provides market segments by type and shape, as well as end-user industries and regions.
Global Immunoassay Market
The Global Immunoassay Market was valued at $xx Mn in 2019 and is expected to reach $xx Mn by 2026, at a CAGR of xx%.
Global Immunoassay Market Overview
Immunoassays are bio analytical methods in which the quantitation of the analyte depends on the reaction of an antigen and an antibody. Immunoassays have been widely used in many important areas of pharmaceutical analysis such as diagnosis of diseases, therapeutic drug monitoring, clinical pharmacokinetics and bioequivalence studies in drug discovery and pharmaceutical industries. The importance and widespread of immunoassay methods in the pharmaceutical analysis are attributed to their inherent specificity, high-throughput, and high sensitivity for the analysis of the wide range of analytes in biological samples. Recent improvements are achieved in the field of immunoassay development for the purposes of pharmaceutical analysis.
The prevalence and incidence of cancer cases are dramatically increasing globally, thus the application of immunoassay for early diagnosis and monitoring of cancer is growing gradually. According to American Cancer Society, lung cancer is one of the most common forms of cancer. In 2018, nearly 2.09 million people across the globe were living with lung cancer, and according to the WHO, this number is expected to increase by 2.27 million by 2020. Immunoassays have been one of the fast-growing clinical diagnostics technologies over the years. The technological advancements in immunoassays driven by the need for early detection of diseases have supported their adoption over the years, and hence have supported the immunoassay market growth.Important advances have been made in the design of immunochemical approaches that allow small molecules, such as drugs, metabolites, and toxins, to substitute dynamic format assays with non-competitive formats, bringing advantages are previously seen only with large molecular analytes.
The report has profiled fifteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analysing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on availability of advanced technology and new techniques
The report contains detailed analysis of Strengths, Weakness and opportunities of the key players operating in the Immunoassy Market. It also provides information on current market trends, competitive ranking analysis, regional bifurcation, turnover forecasts, industry drivers and the key challenges.
Get a Sample PDF of the Report at : Request Free Sample Report
The Market Impact of COVID-19
The COVID-19 epidemic has quickly spreaded since its inception in Wuhan (China), in December 2019.
All around the globe. As of March 2020, the US and China were the most affected. The COVID-19 crisis has had a significant impact on many countries, resulting in travel bans or lockdowns. Industries. This outbreak has severely affected the global food and beverage industries.
This includes office closures, cancellations of technology events, and supply chain disruptions. China is the world’s largest manufacturing country and has the largest number of raw material suppliers. COVID-19 has an adverse effect on overall production because it closes factories and creates supply chain challenges. Market growth.
Segmentation of Global Immunoassay Market by Types and Applications:
Radioimmunoassays have wide applications in cancer detection, blood screening for hepatitis, diagnosis of ulcers, and narcotics detection. These assays are capable of the quantification of very small concentrations of antigens from small volumes of samples with the help of radioisotopes, such as iodine-125 and iodine-131. The growth in this immunoassay market is primarily driven by the increasing prevalence of cancer across the globe and the resultant increase in suitable diagnostic technologies. However, these assays are relatively high-cost assays and have potential health hazards owing to the use of radioactive antigens. This, along with additional expenses towards maintaining radiation safety and disposal protocols limit their wide-scale use. Owing to these, radioimmunoassay is increasingly being replaced by EIAs... less
